Brodalumab Subcutaneous and Ropinirole Extended-Release Tablets
Determining the interaction of Brodalumab Subcutaneous and Ropinirole Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brodalumab
Brand name: Siliq
Synonyms: Brodalumab
Generic Name: ropinirole
Brand name: Requip, Requip XL, ReQuip Follow on Pack, ReQuip Starter Pack, Repreve, Requip Starter Kit
Synonyms: Ropinirole, ROPINIRole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brodalumab Subcutaneous-Ropinirole Hydrochloride
- Brodalumab Subcutaneous-Ropinirole Tablets
- Brodalumab Subcutaneous-Ropivacaine
- Brodalumab Subcutaneous-Ropivacaine Hydrochloride
- Brodalumab Subcutaneous-Ropivacaine Injection
- Brodalumab Subcutaneous-Rosac
- Ropinirole Extended-Release Tablets-Brodspec
- Ropinirole Extended-Release Tablets-Brom Mal Phenyl HCl Dex HBr
- Ropinirole Extended-Release Tablets-Bromaline
- Ropinirole Extended-Release Tablets-Bromaline DM
- Ropinirole Extended-Release Tablets-Bromatan Plus
- Ropinirole Extended-Release Tablets-Bromatan-DM